LEADER MEDICAL GENETICS AND GENOMICS

Leader Medical Genetics and Genomics, Co., Ltd. (LMGG) was established in 2014 as a spin-off company from the Genomic Medicine Project (GMP) supported by the Thailand Center of Excellence for Life Sciences (TCELS). The main objective of LMGG is to bring Genetic and Genomic Medicine technology to serve public both in government and private sectors conveninently such as gene analysis in genetic diseases, genetic prediction for drug allergy and metabolism, premarital and pre-conceptual genetic screening, prevention of genetic diseases in family using assisting reproductive and pre-implantation genetic technologies and genetic counseling service. To date, genetic and genomic technology has a large barrier in clinical service due to the expensive cost and the institutes that can perform the tests are not widely available. LMGG technology is well supported by GMP, especially, Next-Generation Sequencing (NGS) and Capillary Sequencing technologies. Therefore, gene analysis of several genetic..

Also known as: Leader Medical Genetics and Genomics, Co., Ltd, LMGG